Skip to main content

European agency panel recommends approval of J&J's Ebola vaccine

A panel of the European health regulator on Friday recommended approving Johnson & Johnson's two-dose experimental vaccine for Ebola in the European Union.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.